The induction of antigen-specific responses by DEVs has been demonstrated by the activation of tumor-specific CD4+ and CD8+ T cells via engagement of their TCR and is superior to the induction of T cell responses by TDEVs [133,134]. Here, CD8A is linked to neoplasm.